Suppr超能文献

强直性脊柱炎患者肾脏疾病的谱型与预后

Spectrums and Prognosis of Kidney Disease in Patients with Ankylosing Spondylitis.

作者信息

He Dafeng, Wang Rong, Liang Shaoshan, Liang Dandan, Xu Feng, Zeng Caihong, Tang Zheng

机构信息

National Clinical Research Center of Kidney Disease, Jinling Medical College of Nanjing Medical University, Najing, China.

Nephrology Department, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China.

出版信息

Kidney Dis (Basel). 2020 Nov;6(6):444-452. doi: 10.1159/000509248. Epub 2020 Aug 26.

Abstract

BACKGROUND/AIMS: Renal involvement was a common extra-articular manifestation of ankylosing spondylitis (AS). Few reports have investigated the pathological characteristics and renal outcomes of AS patients with kidney disease. The aim of this study was to investigate the pathological spectrums and the renal prognosis of AS patients with kidney disease.

METHODS

This retrospective and observational study was conducted working on 62 patients (47 males and 15 females) with a diagnosis of AS (ACR, 1984) and renal biopsies between 2008 and 2017. The histopathological findings and associated clinical manifestations were collected, and the renal prognoses of patients with kidney disease were evaluated too. Multivariate binary logistic regression analysis was performed to identify risk factors for the occurrence of IgA nephropathy (IgAN).

RESULTS

Renal biopsy revealed that IgAN accounted for a majority (74.2%) of the kidney disease with AS, while membranous nephropathies, minimal change disease, focal segmental glomerulosclerosis, and other lesions accounted for a small minority. Multivariate analysis revealed that serum immunoglobulin A >3.45 g/L and immunoglobulin G >9.06 g/L were risk factors for the occurrence of IgAN. With a median follow-up time of 24.3 months, 28 patients (50.9%) reached complete remission, 9 patients (16.4%) had partial remission, and 1 patient had an eGFR decline >30%. No difference was found in prognosis between IgAN and non-IgAN.

CONCLUSION

IgAN occurred in 76.4% of the kidney disease with AS, and higher serum immunoglobulin A and G increased the risk for the occurrence of IgAN. The renal prognosis of kidney disease in AS was good.

摘要

背景/目的:肾脏受累是强直性脊柱炎(AS)常见的关节外表现。很少有报告研究患有肾脏疾病的AS患者的病理特征和肾脏结局。本研究的目的是调查患有肾脏疾病的AS患者的病理谱和肾脏预后。

方法

本回顾性观察研究纳入了2008年至2017年间62例诊断为AS(1984年美国风湿病学会标准)且接受了肾活检的患者(47例男性和15例女性)。收集组织病理学结果及相关临床表现,并评估肾脏疾病患者的肾脏预后。进行多因素二元逻辑回归分析以确定IgA肾病(IgAN)发生的危险因素。

结果

肾活检显示,IgAN在AS相关肾脏疾病中占大多数(74.2%),而膜性肾病、微小病变病、局灶节段性肾小球硬化及其他病变占少数。多因素分析显示,血清免疫球蛋白A>3.45 g/L和免疫球蛋白G>9.06 g/L是IgAN发生的危险因素。中位随访时间为24.3个月,28例患者(50.9%)达到完全缓解,9例患者(16.4%)部分缓解,1例患者的估算肾小球滤过率下降>30%。IgAN和非IgAN患者的预后无差异。

结论

IgAN在AS相关肾脏疾病中占76.4%,血清免疫球蛋白A和G升高会增加IgAN发生的风险。AS患者肾脏疾病的肾脏预后良好。

相似文献

1
Spectrums and Prognosis of Kidney Disease in Patients with Ankylosing Spondylitis.
Kidney Dis (Basel). 2020 Nov;6(6):444-452. doi: 10.1159/000509248. Epub 2020 Aug 26.
4
Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
Kidney Blood Press Res. 2015;40(2):200-6. doi: 10.1159/000368495. Epub 2015 Apr 6.
5
Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Int Immunopharmacol. 2019 Jan;66:13-18. doi: 10.1016/j.intimp.2018.10.044. Epub 2018 Nov 9.
6
Prognostic factors affecting long-term outcomes in patients with concurrent IgA nephropathy and membranous nephropathy.
Heliyon. 2023 Dec 9;10(1):e23436. doi: 10.1016/j.heliyon.2023.e23436. eCollection 2024 Jan 15.
7
Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Int Immunopharmacol. 2020 Nov;88:106896. doi: 10.1016/j.intimp.2020.106896. Epub 2020 Oct 14.
8
Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
Am J Nephrol. 2021;52(6):507-518. doi: 10.1159/000516187. Epub 2021 Jun 16.
9
Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
Clin Exp Med. 2019 Nov;19(4):479-486. doi: 10.1007/s10238-019-00580-9. Epub 2019 Sep 21.

引用本文的文献

3
Causal effects of rheumatoid arthritis or ankylosing spondylitis on membranous nephropathy: a two-sample Mendelian randomization study.
Clin Kidney J. 2023 Sep 29;16(12):2605-2613. doi: 10.1093/ckj/sfad209. eCollection 2023 Dec.
4
Focal Segmental Glomerulosclerosis and Hyalinosis in a Patient with Spondyloarthritis: A Rare Renal Involvement Case Report.
Mediterr J Rheumatol. 2023 Jun 30;34(2):257-261. doi: 10.31138/mjr.34.2.257. eCollection 2023 Jun.
5
Kidney Disease in Ankylosing Spondylitis: a case series and review of the literature.
J Bras Nefrol. 2023 Jan-Mar;45(1):36-44. doi: 10.1590/2175-8239-JBN-2022-0008.

本文引用的文献

1
Comparison of secondary IgA nephropathy in patients with ankylosing spondylitis and rheumatoid arthritis.
Mod Rheumatol. 2020 Jul;30(4):648-656. doi: 10.1080/14397595.2019.1651493. Epub 2019 Nov 22.
2
Renal amyloidosis in ankylosing spondylitis: A monocentric study and review of literature.
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):386-391. doi: 10.4103/1319-2442.229291.
3
Risk Factors of Renal Involvement Based on Different Manifestations in Patients with Ankylosing Spondylitis.
Kidney Blood Press Res. 2018;43(2):367-377. doi: 10.1159/000488071. Epub 2018 Mar 8.
4
New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.
Ther Adv Chronic Dis. 2018 Mar;9(3):77-87. doi: 10.1177/2040622317743486. Epub 2017 Dec 14.
5
IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Kidney Int. 2018 Mar;93(3):700-705. doi: 10.1016/j.kint.2017.10.019. Epub 2018 Jan 10.
6
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
PLoS One. 2018 Jan 11;13(1):e0190967. doi: 10.1371/journal.pone.0190967. eCollection 2018.
7
Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study.
Korean J Intern Med. 2017 Sep;32(5):916-922. doi: 10.3904/kjim.2015.313. Epub 2017 Aug 11.
9
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22.
10
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.
Ann Rheum Dis. 2017 Jun;76(6):1123-1132. doi: 10.1136/annrheumdis-2016-210000. Epub 2017 Jan 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验